A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

Non-enzymatic, Serum-free Tissue Culture of Pre-invasive Breast Lesions for Spontaneous Generation of Mammospheres

11.5K views

⸱

DOI:

10.3791/51926

⸱

November 8th, 2014

 ,  , 

In This Article

Summary

Primary cell culture using intact tissue organoids provides a model system that mimics the multi-cellular in vivo microenvironment. We developed a serum-free primary breast epithelium tissue culture model that perpetuates mixed cell culture lineages and exhibits differentiated morphology, without enzymatic tissue disruption. Breast organoids remain viable for >6 months.

Abstract

Breast ductal carcinoma in situ (DCIS), by definition, is proliferation of neoplastic epithelial cells within the confines of the breast duct, without breaching the collagenous basement membrane. While DCIS is a non-obligate precursor to invasive breast cancers, the molecular mechanisms and cell populations that permit progression to invasive cancer are not fully known. To determine if progenitor cells capable of invasion existed within the DCIS cell population, we developed a methodology for collecting and culturing sterile human breast tissue at the time of surgery, without enzymatic disruption of tissue.

Sterile breast tissue containing ductal segments is harvested from surgically excised breast tissue following routine pathological examination. Tissue containing DCIS is placed in nutrient rich, antibiotic-containing, serum free medium, and transported to the tissue culture laboratory. The breast tissue is further dissected to isolate the calcified areas. Multiple breast tissue pieces (organoids) are placed in a minimal volume of serum free medium in a flask with a removable lid and cultured in a humidified CO2 incubator. Epithelial and fibroblast cell populations emerge from the organoid after 10 - 14 days. Mammospheres spontaneously form on and around the epithelial cell monolayer. Specific cell populations can be harvested directly from the flask without disrupting neighboring cells. Our non-enzymatic tissue culture system reliably reveals cytogenetically abnormal, invasive progenitor cells from fresh human DCIS lesions.

Introduction

Proliferation of epithelial cells within the confines of breast ducts and alveoli (ductal carcinoma in situ) is recognized as an obligate precursor to invasive ductal and lobular breast carcinoma. Nevertheless, the molecular mechanisms and cell population dynamics that permit progression to invasive cancer are poorly understood. Elucidating the survival mechanisms used by pre-invasive breast carcinoma cells, or any pre-invasive tumor, may reveal therapeutic strategies for killing, or even preventing, pre-invasive neoplasms1. However, simple low-cost methods for functionally studying human pre-invasive lesions have been lacking. Although in vitr....

Access restricted. Please log in or start a trial to view this content.

Protocol

Human breast tissue was collected from patients enrolled in a research study, with written informed consent, following Department of Defense, George Mason University, and Inova Health System Institutional Review Board’s approved protocols.

1. Prepare Nutrient Rich Medium with Growth Factors and Antibiotics

  1. Prepare stock solutions of insulin, epidermal growth factor (EGF), streptomycin sulfate and gentamicin sulfate.
    1. Reconstitute insulin in sterile filtered water to a final concentration of 10 mg/ml. Aspirate 10 ml of Type 1 reagent grade water in a sterile 10 ml disposable syringe. Attach a 0.22 µm polyeth....

Access restricted. Please log in or start a trial to view this content.

Results

Workflow for procuring and culturing sterile breast ductal carcinoma in situ tissue

Breast tissue sterility is maintained from the operating room to the cell culture lab via minor changes in typical hospital pathology workflow (Figure 1). Tissue is transported in a sterile container with a plastic film cover which allows radiologic assessment while maintaining tissue sterility. Gross tissue processing of a breast lumpectomy or mastectomy sample is performed with sterile .......

Access restricted. Please log in or start a trial to view this content.

Discussion

The culture system described herein constitutes a new model for generating living pre-invasive neoplastic breast cells for basic and translational research studies. In the past, pre-malignant breast cancer progression has typically been studied using three different methods. The first method is histopathologic and genetic analysis of microdissected frozen or fixed human specimens12-14. The second method utilizes mouse models that contain hyperplastic alveolar nodules (HAN lesions) that are thought to be simila.......

Access restricted. Please log in or start a trial to view this content.

Disclosures

The authors have nothing to disclose.

Acknowledgements

This work was supported partially by (1) the Department of Defense Breast Cancer Research Program (US Army Medical Research Acquisition Activity) award #W81XVVH-10-1-0781 to LAL and VE, and (2) the Susan G. Komen Foundation grant IR122224446 to LAL and VE. Pathology support and tissue grossing was kindly provided by Inova Fairfax Pathology Department, Dr. Hassan Nayer, Dr. Geetha A. Menezes, and Dr. Charles Bechert. Patient consent and sample procurement was expertly guided by Inova Fairfax Hospital clinical research coordinators Holly Gallimore, Heather Huryk, and Emil Kamar.

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
EthanolFisherA405-Pprepare a 70% solution in Type 1 reagent grade water
18 MΩ-cm water, sterile filteredsterile filtered, Type 1 reagent grade water
10 cc plastic disposable syringe, sterileBD305482
0.2 µm polyethersulfone (PES) syringe filter, sterileThermo Scientific194-2520
15 ml polypropylene conical tubes, sterileFisher14-959-49B
50 ml polypropylene conical tubes, sterileFisher05-539-6
1.5 ml low retention microcentrifuge tubes, sterileFisher02-681-331
nutrient medium, DMEM-F12/HEPESInvitrogen11330-032with L-glutamine
Insulin, human recombinantRoche1137649700110 mg/ml stock
Epidermal Growth Factor (EGF), human recombinantMilliporeGF144100 µg/ml stock
Streptomycin sulfateSigma-AldrichS156710 mg/ml stock
Gentamicin sulfateSigma-AldrichG1911410 mg/ml stock
Filtration flask and filter top, sterileMilliporeSCGPU02RE0.22 µm PES membrane
25 ml sterile, disposable pipettesFisher4489paper-plastic wrapped
10 ml sterile, disposable pipettesFisher4488paper-plastic wrapped
Tissue marking dyes (black, blue, red, green, yellow and orange)CDIMD2000after opening use only with single-use, sterile cotton tipped applicators, or use once and discard
Cotton tipped applicators, sterileFisher23-400-115single use only
Gauze pads, 10 x 10 cm, sterileFisher2187
Plastic transfer pipettes, sterile, disposableSamco202-20S
Vinegar, white distilledhousehold use5% acetic acid; after opening use only with sterile pipettes
#10 scalpels, sterile, disposableThermo Scientific31-200-32
Petri dish, sterileFisherFB0875713A
TPP 115 cm2 flask, with removable lidMidSci90652screw cap with filter
CO2 incubatorFisher13-998-0745% CO2, 37 °C, humidified chamber
inverted light microscopeOlypmusIX51
8 M ureaFisherBP169-500optional, for mass spectrophotometric analysis of cultured cells
2X SDS tris-glycine bufferLife TechnologiesLC2676optional, for proteomic analysis of cultured cells
CytocentrifugeThermo ScientificA78300003optional, for preparing cell smears

References

  1. Shaughnessy, J. A., et al. Treatment and prevention of intraepithelial neoplasia: an important target for accelerated new agent development. Clin Cancer Res. 8 (2), 314-346 (2002).
  2. Lee, J., et al.

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Explore More Articles

Non-enzymatic Tissue CultureSerum-free MediumBreast Tissue OrganoidsMammosphere FormationDuctal Carcinoma In SituEpithelial Cell EmergenceSterile Tissue ProcessingSpontaneous Mammosphere GenerationCytogenetically Abnormal CellsInvasive Progenitor Cells